-
International Medical Case Reports Journal
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Herpes zoster in the T1 dermatome presenting with Horner’s syndrome, radicular weakness, and postherpetic neuralgia
Case report
(13405) Total Article Views
Authors: W Oliver Tobin, Byron R Spencer, Bart M Demaerschalk
Published Date October 2008
Volume 2008:1 Pages 1 - 2
DOI: http://dx.doi.org/10.2147/IMCRJ.S4008
W Oliver Tobin1, Byron R Spencer2, Bart M Demaerschalk2
1Department of Neurology, Adelaide and Meath Hospital, Dublin, incorporating the National Children’s Hospital, Ireland; 2Department of Neurology, Mayo Clinic Arizona, USA
Abstract: Herpes zoster is caused by varicella zoster virus infection involving the dorsal root ganglia of spinal nerve roots. This common problem can be associated with multiple neurological abnormalities. We present a case of Herpes zoster affecting the T1 dermatome associated with ipsilateral Horner’s syndrome and radicular weakness.
Keywords: Herpes zoster, Horner’s syndrome, spinal ganglia, postherpetic neuralgia, spinal nerve roots
Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Readers of this article also read:
- Testimonials
"I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University.
- Interested in being a peer-reviewer?
Click here to register.
- Effects of selective serotonin reuptake inhibitors on motor neuron survival
- Amino acid management of Parkinson’s disease: a case study
- Emerging incidence of Lyme borreliosis, babesiosis, bartonellosis, and granulocytic ehrlichiosis in Australia
- Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
